Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
untitled letter
Marketing
Novartis earns FDA ire for ‘misleading’ Fabhalta ad imagery
The FDA is not feeling the love in a commercial for Novartis’ paroxysmal nocturnal hemoglobinuria treatment Fabhalta.
Andrea Park
Sep 30, 2025 11:12am
FDA accuses Mayne of giving misleading impression of drug safety
May 13, 2025 9:30am
FDA calls out 'concerning' claims on site for Taiho's Lytgobi
Mar 26, 2025 1:21pm
FDA blasts Edenbridge over 'misleading' exhibit booth panel
Mar 5, 2025 9:55am
FDA slams Merz over 'misleading' Instagram ad for Botox rival
Nov 14, 2024 9:54am
FDA slams AbbVie for misleading claims in Serena Williams ad
Sep 12, 2024 6:48am
